Search

Author/Creator Outtier, An

1. Effect of vedolizumab dose intensification on serum drug concentrations and regain of response in inflammatory bowel disease patients with secondary loss of response. Issue 2 (28th February 2021)

Authors:
Outtier, An; Wauters, Lucas; Rahier, Jean‐Francois; Bossuyt, Peter; Colard, Arnaud; Franchimont, Denis; Lambrecht, Guy; Macken, Elisabeth; Van Moerkercke, Wouter; Baert, Filip; Humblet, Evelien; Van Hootegem, Philippe; Gils, Ann; Ferrante, Marc; Vermeire, Séverine
Journal:
GastroHep
Issue:
Volume 3:Issue 2(2021)
Page Start:
63
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD Patients. (29th August 2019)

Authors:
Verstockt, Bram; Mertens, Evelien; Dreesen, Erwin; Outtier, An; Noman, Maja; Tops, Sophie; Schops, Ganel; Van Assche, Gert; Vermeire, Séverine; Gils, Ann; Ferrante, Marc
Journal:
Journal of Crohn's and colitis
Issue:
Volume 14:Number 3(2020)
Page Start:
332
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis. Issue 2 (28th April 2022)

Authors:
Verstockt, Bram; Volk, Valery; Jaeckel, Charlot; Alsoud, Dahham; Sabino, João; Nikolaus, Susanna; Outtier, An; Krönke, Nicole; Feuerhake, Friedrich; De Hertogh, Gert; Rosenstiel, Philip; Vermeire, Séverine; Schreiber, Stefan; Ferrante, Marc; Aden, Konrad
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 56:Issue 2(2022)
Page Start:
282
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Multi‐model averaging improves the performance of model‐guided infliximab dosing in patients with inflammatory bowel diseases. (15th June 2022)

Authors:
Kantasiripitak, Wannee; Outtier, An; Wicha, Sebastian G.; Kensert, Alexander; Wang, Zhigang; Sabino, João; Vermeire, Séverine; Thomas, Debby; Ferrante, Marc; Dreesen, Erwin
Journal:
CPT: pharmacometrics & systems pharmacology
Issue:
Volume 11:Number 8(2022)
Page Start:
1045
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune‐mediated inflammatory diseases: A European retrospective observational study. Issue 10 (25th October 2021)

Authors:
Goessens, Laurent; Colombel, Jean‐Frédéric; Outtier, An; Ferrante, Marc; Sabino, Joao; Judge, Ciaran; Saeidi, Reza; Rabbitt, Louise; Armuzzi, Alessandro; Domenech, Eugeni; Michalopoulos, George; Cremer, Anneline; García‐Alonso, Francisco Javier; Molnar, Tamas; Karmiris, Konstantinos; Gecse, Krisz...
Journal:
United European Gastroenterology journal
Issue:
Volume 9:Issue 10(2021)
Page Start:
1136
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates. (8th February 2019)

Authors:
Verstockt, Bram; Dreesen, Erwin; Noman, Maja; Outtier, An; Van den Berghe, Nathalie; Aerden, Isolde; Compernolle, Griet; Van Assche, Gert; Gils, Ann; Vermeire, Séverine; Ferrante, Marc
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13:Number 7(2019)
Page Start:
864
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗